🇺🇸 Renoquid in United States

FDA authorised Renoquid on 12 September 1975

Marketing authorisations

FDA — authorised 12 September 1975

  • Status: approved

FDA — authorised 12 September 1975

  • Application: NDA017569
  • Marketing authorisation holder: GLENWOOD
  • Local brand name: RENOQUID
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Renoquid in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is Renoquid approved in United States?

Yes. FDA authorised it on 12 September 1975; FDA authorised it on 12 September 1975.

Who is the marketing authorisation holder for Renoquid in United States?

Marketing authorisation holder not available in our data.